Wells Fargo & Company Motus Gi Holdings, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	BUY	$4.8 - $7.24 $340 - $514	71 Added 17.88%	468 $0
Q1 2022 May 16, 2022	BUY	$6.3 - $9.86 $6 - $9	1 Added 0.25%	397 $0
Q4 2021 Feb 14, 2022	BUY	$8.58 - $15.54 $8 - $15	1 Added 0.25%	396 $0
Q3 2021 Nov 15, 2021	BUY	$13.8 - $20.6 $289 - $432	21 Added 5.61%	395 $0
Q2 2021 Aug 16, 2021	BUY	$17.92 - $27.8 $1,505 - $2,335	84 Added 28.97%	374 $0
Q1 2021 May 13, 2021	SELL	$19.88 - $49.2 $19 - $49	-1 Reduced 0.34%	290 $0
Q4 2020 Feb 09, 2021	BUY	$14.2 - $23.8 $411 - $690	29 Added 11.07%	291 $0
Q3 2020 Nov 05, 2020	SELL	$19.3 - $27.2 $64,674 - $91,147	-3,351 Reduced 92.75%	262 $0
Q2 2020 Aug 13, 2020	BUY	$12.18 - $29.0 $18,282 - $43,529	1,501 Added 71.07%	3,613 $5,000
Q1 2020 May 14, 2020	BUY	$9.94 - $54.8 $20,993 - $115,737	2,112 New	2,112 $1,000

About Motus GI Holdings, Inc.

Ticker MOTS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 2,996,840
Description
Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.

More about MOTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.